UCLA Health TechQuity Accelerator
Investing in Innovation for an Equitable Future
TechQuity seeks to advance health equity and community health resiliency for populations most impacted through the COVID-19 pandemic by working with mission-driven startups.
UCLA Health is at the forefront of cutting-edge technology in patient care. TechQuity offers an opportunity for early-stage companies at intersection of the clinical excellence and regional connectivity.
- ACCELERATE access to end users and leading clinical and public health experts.
- AMPLIFY diverse talents, assets, and infrastructure in Los Angeles and Southern California.
- SCALE community and investor network through personalized mentorship.
Digital tools to promote health education and communication and physical devices to reduce exposure risk through monitoring, automation, or vaccination.
Diagnostic devices or accessories with a focus on rapid, accessible, and scalable point of care or at home testing, as well as digital platforms for population health surveillance.
Devices and treatments for the management and treatment of acute and long-term health impacts of COVID-19 and the associated health outcomes, including but not limited to, pulmonary critical care, cardiology, and mental health.
Actionable interventions, such as accessibility to healthcare through digital platforms or tech-enabled services and inclusive indications for vulnerable populations.
Together with BioscienceLA, TechQuity is committed to building a diverse life science workforce by providing career-building opportunities for individuals from historically underrepresented backgrounds. Participants in the UCLA Health TechQuity Accelerator will be paired with student interns that will be subsidized by BioscienceLA, as part of its BioFutures Internship Program.
TechQuity seeks applications from teams with unique innovations addressing pandemic response and resilience across four themes: prevention, diagnosis, treatment, and community impact. Our aim is to rapidly address the economic, health, and safety risks caused by the pandemic by deploying innovative bioscience technologies with the focus on workforce safety and security, enterprise agility, digital transformation, automation and community health resiliency to improve economic development and health equity in our region and beyond.
Teams should have evidence of commercial potential. This could include product proof of concept, working prototype, benchtop or preclinical data, or early user traction.
TechQuity welcomes applications from pre-seed and seed stage teams to apply from February 15th to March 31st, 2022.
Sensitive and Fast COVID-19 Testing
The UCLA–developed diagnostic technology has helped keep the university and other large client organizations operational during the pandemic.
Global Equity at Stake Again
The emergence of the omicron SARS-coronavirus-2 variant has world leaders, scientists and the general public bracing for another possible COVID-19 surge.
Your company is a good fit if:
- You are a team of passionate innovators seeking to transform healthcare.
- Your technology is a novel product or platform seeking to solve gaps in long term health exacerbated or created by the COVID-19 pandemic.
- You are able to allocate 4 – 6 hours per week for programming and bi-weekly personalized mentorship during the period of the program (10 weeks).
- You have at least an early working prototype and data validating your innovation. Your innovation is ready to pilot in the next 6 – 12 months.
Q: Does the UCLA Health Accelerator take equity?
A: UCLA health Accelerator is a zero-equity accelerator.
Q: Can my company participate from anywhere in the world?
A: TechQuity is an accelerator for US based companies.
Q: How do I apply to the TechQuity Accelerator?
A: Have your pitch deck and information about your product and company to apply here.
Q: When should I apply?
A: Our review process is rolling. As soon as you apply we review your application and communicate with you. The deadline for applications is March 31st.
To learn more about the UCLA Health TechQuity Accelerator, contact:
Leyla Mirmomen, PhD